Marijuana Research Today is a free monthly online journal that collates and summarizes the latest research about Marijuana, including details on benefits, cancer, effects, uses, addiction.

Volume 3 (2006), Issue 3 (March)

1. Comorbid substance use and age at onset of schizophrenia.
   Br J Psychiatry, 188: 237-42. [Abstract] [Full-text]
2. Common use in the general population of sexual enrichment AIDS and drugs to enhance sexual experience.
   Sex Transm Dis, 33(3): 156-62. [Abstract] [Full-text]
3. Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls.
   J Psychopharmacol, 20(2): 302-11. [Abstract] [Full-text]
4. The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview.
   J Psychopharmacol, 20(2): 188-93. [Abstract] [Full-text]
5. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
   J Psychopharmacol, 20(2): 147-63. [Abstract] [Full-text]
6. Disruption of PTEN coupling with 5-HT2C receptors suppresses behavioral responses induced by drugs of abuse.
   Nat Med, 12(3): 324-9. [Abstract] [Full-text]
7. The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells.
   Biochem Pharmacol, 71(8): 1146-54. [Abstract] [Full-text]
8. Project Towards No Drug Abuse: long-term substance use outcomes evaluation.
   Prev Med, 42(3): 188-92. [Abstract] [Full-text]
9. Neuropsychological deficits in long-term frequent cannabis users.
   Neurology, 66(5): 737-9. [Abstract] [Full-text]
10. Overlap of clusters of psychiatric symptoms among clients of a comprehensive addiction treatment service.
    Psychol Addict Behav, 20(1): 28-35. [Abstract] [Full-text]
11. Chemical characterization of lignin and lipid fractions in industrial hemp bast fibers used for manufacturing high-quality paper pulps.
    J Agric Food Chem, 54(6): 2138-44. [Abstract] [Full-text]
12. A meta-analysis of negative symptoms in dual diagnosis schizophrenia.
    Psychol Med, 36(4): 431-40. [Abstract] [Full-text]
13. Comparison of smoking, drinking, and marijuana use between students present or absent on the day of a school-based survey.
    J Sch Health, 76(4): 133-7. [Abstract] [Full-text]
14. Cannabidiol reverses MK-801-induced disruption of prepulse inhibition in mice.
    Neuropsychopharmacology, 31(4): 795-803. [Abstract] [Full-text]
15. A mixed-effects regression model for longitudinal multivariate ordinal data.
    Biometrics, 62(1): 261-8. [Abstract] [Full-text]
16. Illicit and traditional drug use among ethnic minority adolescents in East London.
    Public Health, 120(4): 329-38. [Abstract] [Full-text]
17. The association between heroin use and anxiety sensitivity among inner-city individuals in residential drug use treatment.
    Behav Res Ther, 44(5): 667-77. [Abstract] [Full-text]
18. Projecting drug use among aging baby boomers in 2020.
    Ann Epidemiol, 16(4): 257-65. [Abstract] [Full-text]
19. On cannabis, chloral hydrate, and career cycles of psychotropic drugs in medicine.
    Bull Hist Med, 80(1): 95-114. [Abstract] [Full-text]
20. Herbal products and their association with substance use in adolescents.
    J Adolesc Health, 38(4): 395-400. [Abstract] [Full-text]
21. Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis.
    Addiction, 101(4): 556-69. [Abstract] [Full-text]
22. Further characterization of the time-dependent vascular effects of delta9-tetrahydrocannabinol.
    J Pharmacol Exp Ther, 317(1): 428-38. [Abstract] [Full-text]
23. Long-term effects of frequent cannabis use on working memory and attention: an fMRI study.
    Psychopharmacology (Berl), 185(3): 358-68. [Abstract] [Full-text]
24. The relationship between youth's moral and legal perceptions of alcohol, tobacco and marijuana and use of these substances.
    Health Educ Res, 21(2): 276-86. [Abstract] [Full-text]
25. Interaction between maternal smoking and malnutrition in infant risk of gastroschisis.
    Birth Defects Res A Clin Mol Teratol, 76(3): 182-6. [Abstract] [Full-text]
26. Sativex: clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain.
    Expert Opin Pharmacother, 7(5): 607-15. [Abstract] [Full-text]
27. Patterns and perceptions of ecstasy use among young, low-income women.
    Addict Behav, 31(4): 676-85. [Abstract] [Full-text]
28. Attachment, fear of intimacy and differentiation of self among clients in substance disorder treatment facilities.
    Addict Behav, 31(4): 732-7. [Abstract] [Full-text]
29. Joint trajectories of gambling, alcohol and marijuana use during adolescence: a person- and variable-centered developmental approach.
    Addict Behav, 31(4): 566-80. [Abstract] [Full-text]
30. Decreased depression in marijuana users.
    Addict Behav, 31(4): 738-42. [Abstract] [Full-text]
31. A brief history of cannabinoid and endocannabinoid pharmacology as inspired by the work of British scientists.
    Trends Pharmacol Sci, 27(3): 134-40. [Abstract] [Full-text]
32. Associations between substance use and sexual risk among very young men who have sex with men.
    Sex Transm Dis, 33(4): 265-71. [Abstract] [Full-text]
33. Genetic Variation in Hemp and Marijuana (Cannabis sativa L.) According to Amplified Fragment Length Polymorphisms.
    J Forensic Sci, 51(2): 371-5. [Abstract] [Full-text]
34. Variables associated with perceived sleep disorders in methadone maintenance treatment (MMT) patients.
    Drug Alcohol Depend, 82(2): 103-10. [Abstract] [Full-text]
35. Cannabinoids in medicine: A review of their therapeutic potential.
    J Ethnopharmacol, 105(1): 1-25. [Abstract] [Full-text]
36. How many sites of action for endocannabinoids to control energy metabolism?
    Int J Obes (Lond), 30: S39-43. [Abstract] [Full-text]
37. Mechanisms of CB1 receptor signaling: endocannabinoid modulation of synaptic strength.
    Int J Obes (Lond), 30: S19-23. [Abstract] [Full-text]
38. Effects of prenatal marijuana on visuospatial working memory: An fMRI study in young adults.
    Neurotoxicol Teratol, 28(2): 286-95. [Abstract] [Full-text]
39. A 12-month prospective follow-up study of patients with schizophrenia-spectrum disorders and substance abuse: Changes in psychiatric symptoms and substance use.
    Schizophr Res, 83(1): 65-75. [Abstract] [Full-text]
40. Cannabis dependence and mental health perception amongst people diverted by police after arrest for cannabis-related offending behaviour in Australia.
    Crim Behav Ment Health, 15(4): 249-260. [Abstract] [Full-text]
41. Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction.
    J Psychopharmacol, 20(3): 373-84. [Abstract] [Full-text]

© 2004-2008 Marijuana Research Today. All Rights Reserved.